Papers: 10.1186/s12935-021-02092-7

https://doi.org/10.1186/s12935-021-02092-7

miR-198 inhibits the progression of renal cell carcinoma by targeting BIRC5

Cited by: 7
Author(s): Chao Yuan, Zhonggen Su, Shengjie Liao, Duanzhuo Li, Zhiwen Zhou, Yawen Wang, Mingchun Quan, Lingling Zeng, Cai Lv, Chenyi Shen, Weida Gong, Jianfeng Wu, Xiaogang Chen, Wenbing Hu, Xu Liang Lv, Wenxia Si, Xuezhong Yu
Published: about 5 years ago

Software Mentions 1